Rachel Whitman
Medical · Portsmouth, NHNPI 1356741151
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 31.8% of the total. Among medical clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$744
- Gilead$209
- Sanofi$193
- Takeda Pharmaceuticals U.S.A., Inc.$170
- Phathom Pharmaceuticals, Inc.$104
- plus $850 from 18 others
What the payments were for
- Food & beverage$3,328100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $1,057 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 68 | $744 |
| Gilead | 5 | $209 |
| Sanofi | 7 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $170 |
| Phathom Pharmaceuticals, Inc. | 1 | $104 |
| Daiichi Sankyo Inc. | 5 | $99 |
| Bristol Myers Squibb | 4 | $97 |
| Ironwood Pharmaceuticals, Inc | 5 | $96 |
| Intercept Pharmaceuticals, Inc. | 3 | $73 |
| Nestle Healthcare Nutrition Inc. | 4 | $71 |
| Ardelyx, Inc. | 2 | $62 |
| Pfizer | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Johnson & Johnson | 2 | $39 |
| QOL Medical, LLC | 1 | $38 |
| Redhill Biopharma Inc. | 2 | $32 |
| Lilly USA, LLC | 1 | $31 |
| Novo Nordisk | 1 | $22 |
| Organon | 1 | $21 |
| Celltrion USA Inc. | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Merck | 1 | $16 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,328 in reported general payments places this provider in the 90th percentile of 124 medical providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 61 | $71,261 |
| Mesalamine | 24 | $14,922 |
| MotegrityPrucalopride Succinate | 15 | $11,053 |
| TrulancePlecanatide | 12 | $10,997 |
| Esomeprazole Magnesium | 42 | $4,387 |
| Omeprazole | 180 | $3,128 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 17 | $2,910 |
| Budesonide DrBudesonide | 22 | $2,470 |
| Pantoprazole Sodium | 102 | $2,051 |
| Dicyclomine Hcl | 69 | $1,544 |
| Sucralfate | 18 | $1,358 |
| Famotidine | 53 | $1,067 |
| Ondansetron Hcl | 22 | $440 |
| Amitriptyline Hcl | 38 | $349 |
| LoperamideLoperamide Hcl | 23 | $234 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,057 | $71,26161 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $170 | $11,05315 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $744 | $10,99712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 124 medical providers in New Hampshire.
Other medical in Portsmouth
- Allison HansenPortsmouth$614
- Allison AllenPortsmouth$551
- Holly PelletierManchester$124K
- Kathrine CecilNashua$9K
- Alyssa DunnDerry$8K
- Kelly HochstetlerDover$8K
- Stacy FilionConcord$5K
- Jacqueline FournierConcord$5K
- Andrea BourkeLondonderry$5K
- Heather BigosDover$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.